2023 Q3 Form 10-Q Financial Statement

#000173910423000013 Filed on August 07, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $1.068B $1.057B
YoY Change 3.89% -10.2%
Cost Of Revenue $487.0M $434.0M
YoY Change 3.18% -10.33%
Gross Profit $581.0M $623.0M
YoY Change 4.5% -10.1%
Gross Profit Margin 54.4% 58.94%
Selling, General & Admin $313.0M $353.0M
YoY Change 5.03% 2.92%
% of Gross Profit 53.87% 56.66%
Research & Development $86.00M $81.00M
YoY Change 10.26% -1.22%
% of Gross Profit 14.8% 13.0%
Depreciation & Amortization $173.0M $177.0M
YoY Change 35.16% 3.51%
% of Gross Profit 29.78% 28.41%
Operating Expenses $399.0M $434.0M
YoY Change 6.12% 2.12%
Operating Profit $182.0M $189.0M
YoY Change 1.11% -29.48%
Interest Expense $72.00M $74.00M
YoY Change 20.0% 10.45%
% of Operating Profit 39.56% 39.15%
Other Income/Expense, Net -$9.000M -$23.00M
YoY Change 12.5%
Pretax Income -$1.097B -$79.00M
YoY Change 2511.9% 338.89%
Income Tax -$1.000M $18.00M
% Of Pretax Income
Net Earnings -$1.096B -$97.00M
YoY Change 2136.73% 340.91%
Net Earnings / Revenue -102.62% -9.18%
Basic Earnings Per Share -$2.22 -$0.20
Diluted Earnings Per Share -$2.22 -$0.20
COMMON SHARES
Basic Shares Outstanding 492.7M shares 492.6M shares
Diluted Shares Outstanding 492.7M shares 492.6M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $369.0M $367.0M
YoY Change -19.78% -27.61%
Cash & Equivalents $369.0M $367.0M
Short-Term Investments
Other Short-Term Assets $371.0M $370.0M
YoY Change 13.8% 9.47%
Inventory $1.690B $1.690B
Prepaid Expenses
Receivables $911.0M $1.000B
Other Receivables $224.0M $225.0M
Total Short-Term Assets $3.565B $3.652B
YoY Change 13.03% 10.43%
LONG-TERM ASSETS
Property, Plant & Equipment $992.0M $1.007B
YoY Change 5.98% 4.79%
Goodwill $4.902B $6.040B
YoY Change -14.24% 2.41%
Intangibles $4.475B $4.678B
YoY Change -6.11% -7.53%
Long-Term Investments $28.00M $27.00M
YoY Change 0.0% -12.9%
Other Assets $410.0M $419.0M
YoY Change 9.04% 11.44%
Total Long-Term Assets $10.78B $12.14B
YoY Change -8.61% -1.22%
TOTAL ASSETS
Total Short-Term Assets $3.565B $3.652B
Total Long-Term Assets $10.78B $12.14B
Total Assets $14.34B $15.80B
YoY Change -4.04% 1.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $296.0M $354.0M
YoY Change -15.43% -8.29%
Accrued Expenses
YoY Change
Deferred Revenue $356.0M $332.0M
YoY Change 19.46% 16.9%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $39.00M $39.00M
YoY Change -90.1% -30.36%
Total Short-Term Liabilities $1.265B $1.284B
YoY Change -21.57% -4.04%
LONG-TERM LIABILITIES
Long-Term Debt $5.870B $6.023B
YoY Change 6.59% 0.27%
Other Long-Term Liabilities $432.0M $411.0M
YoY Change 92.0% 69.83%
Total Long-Term Liabilities $6.302B $6.434B
YoY Change 9.94% 2.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.265B $1.284B
Total Long-Term Liabilities $6.302B $6.434B
Total Liabilities $8.210B $8.376B
YoY Change 0.09% -1.0%
SHAREHOLDERS EQUITY
Retained Earnings -$2.147B -$1.051B
YoY Change 120.88% 13.87%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.134B $7.420B
YoY Change
Total Liabilities & Shareholders Equity $14.34B $15.80B
YoY Change -4.04% 1.25%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$1.096B -$97.00M
YoY Change 2136.73% 340.91%
Depreciation, Depletion And Amortization $173.0M $177.0M
YoY Change 35.16% 3.51%
Cash From Operating Activities $198.0M $61.00M
YoY Change 4.76% -80.45%
INVESTING ACTIVITIES
Capital Expenditures $33.00M $42.00M
YoY Change -171.74% -227.27%
Acquisitions
YoY Change
Other Investing Activities -$3.000M -$1.000M
YoY Change -133.33% -75.0%
Cash From Investing Activities -$36.00M -$43.00M
YoY Change -2.7% 16.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -157.0M 39.00M
YoY Change -7.1% -140.63%
NET CHANGE
Cash From Operating Activities 198.0M 61.00M
Cash From Investing Activities -36.00M -43.00M
Cash From Financing Activities -157.0M 39.00M
Net Change In Cash 5.000M 57.00M
YoY Change -129.41% -68.16%
FREE CASH FLOW
Cash From Operating Activities $198.0M $61.00M
Capital Expenditures $33.00M $42.00M
Free Cash Flow $165.0M $19.00M
YoY Change -29.79% -94.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3900000 shares
CY2023Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
35000000 usd
CY2022Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
86000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
75000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
126000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97000000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
3652000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3279000000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
6040000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5993000000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4678000000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4842000000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
419000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
378000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1007000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
999000000 usd
CY2023Q2 us-gaap Assets
Assets
15796000000 usd
CY2022Q4 us-gaap Assets
Assets
15491000000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
354000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
390000000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
332000000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
324000000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
39000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
388000000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
559000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
600000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1284000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1702000000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6023000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5448000000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
658000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
662000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
411000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
390000000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
8376000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
8202000000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
492554242 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
492554242 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
474237738 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
474237738 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8752000000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8738000000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1051000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1057000000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-281000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-392000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7420000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7289000000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15796000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15491000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
7508000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
51000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
23000000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7585000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-10000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-463000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
7125000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7289000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
103000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
82000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
7480000000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-97000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
29000000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8000000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
7420000000 usd
us-gaap Net Income Loss
NetIncomeLoss
6000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
350000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21000000 usd
elan Asset Impairment Charges Including Inventory Write Down
AssetImpairmentChargesIncludingInventoryWriteDown
0 usd
elan Proceeds From Derivative Instrument Operating Activities
ProceedsFromDerivativeInstrumentOperatingActivities
0 usd
elan Proceeds From Derivative Instrument Operating Activities
ProceedsFromDerivativeInstrumentOperatingActivities
132000000 usd
us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
384000000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
250000000 usd
elan Payments To Acquire Property Plant Equipment And Software
PaymentsToAcquirePropertyPlantEquipmentAndSoftware
66000000 usd
elan Payments To Acquire Property Plant Equipment And Software
PaymentsToAcquirePropertyPlantEquipmentAndSoftware
58000000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-98000000 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
425000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
250000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
563000000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
32000000 usd
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
528000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
738000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-296000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-9000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-19000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-131000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
345000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
638000000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367000000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<div><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1. Basis of Presentation and Summary of Significant Accounting Policies</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have prepared the accompanying unaudited condensed consolidated financial statements in accordance with the SEC requirements for interim reporting. As permitted under those rules, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) have been condensed or omitted. The information included in this Form 10-Q should be read in conjunction with our consolidated financial statements and accompanying notes for the year ended December 31, 2022 included in our </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1739104/000173910423000004/elan-20221231.htm#iabf0ca0eda714084ad9b96b0b7cac563_70" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition, results for interim periods should not be considered indicative of results for any other interim period or for the full year ending December 31, 2023 or any other future period. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the financial statements reflect all adjustments (including those that are normal and recurring) that are necessary for fair presentation of the results of operations for the periods shown. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. Certain reclassifications of prior year information have been made to conform to the current year's presentation.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies set forth in Note 4 to the consolidated financial statements in our </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1739104/000173910423000004/elan-20221231.htm#iabf0ca0eda714084ad9b96b0b7cac563_70" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Form 10-K</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> appropriately represent, in all material respects, the current status of our accounting policies.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:117%">Revision of Previously Issued Consolidated Financial Statements</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the preparation of our financial statements as of and for the year ended December 31, 2022, a cumulative error was identified and corrected relating to the valuation allowance for taxes for a Southeast Asia affiliate. While immaterial to prior years, correcting this cumulative error in 2022 would have caused the 2022 financial statements to be materially misstated. In conjunction with making these corrections, we made other adjustments to the prior years to revise uncorrected errors. The appropriate revisions to our historical condensed consolidated financial statements and the notes thereto are reflected herein. Further information is included in Note 2 and Note 21 to the consolidated financial statements in our </span><span style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1739104/000173910423000004/elan-20221231.htm#iabf0ca0eda714084ad9b96b0b7cac563_70" style="color:#0071cd;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Form 10-K</a></span>.
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1057000000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
316000000 usd
elan Contract With Customer Liability Revenue Recognized Including Current Year Additions
ContractWithCustomerLiabilityRevenueRecognizedIncludingCurrentYearAdditions
355000000 usd
elan Contract With Customer Liability Increase From Cash Receipts
ContractWithCustomerLiabilityIncreaseFromCashReceipts
387000000 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
332000000 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1057000000 usd
CY2022Q1 us-gaap Contract With Customer Asset Gross
ContractWithCustomerAssetGross
55000000 usd
CY2023Q2 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022Q2 us-gaap Restructuring Charges
RestructuringCharges
-1000000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
-7000000 usd
CY2023Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
35000000 usd
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
26000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
75000000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
50000000 usd
CY2023Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
CY2022Q2 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
59000000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
81000000 usd
CY2023Q2 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2022Q2 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-2000000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-2000000 usd
CY2023Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
35000000 usd
CY2022Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
86000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
75000000 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
126000000 usd
CY2022Q4 us-gaap Restructuring Reserve
RestructuringReserve
36000000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
28000000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
8000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2000000 usd
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
900000 shares
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
834000000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
783000000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
773000000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
683000000 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
141000000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
130000000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
1748000000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
1596000000 usd
CY2023Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
58000000 usd
CY2022Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
58000000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1690000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1538000000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
56000000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
64000000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
6062000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
5836000000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
39000000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
388000000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6023000000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5448000000 usd
CY2023Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
29000000 usd
CY2022Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
1000000 usd
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
59000000 usd
CY2023Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
108000000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
27000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
27000000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.230
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.799
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.323
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
23000000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.230
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.799
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000000 usd
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.286
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.323
CY2022Q2 elan Interest Rate Cash Flow Hedge Gain Loss Stranded Tax Benefits Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossStrandedTaxBenefitsReclassifiedToEarningsNet
17000000 usd
CY2023Q2 elan Lessee Operating Lease Lease Not Yet Commenced Liability To Be Paid
LesseeOperatingLeaseLeaseNotYetCommencedLiabilityToBePaid
378000000 usd
CY2023Q2 us-gaap Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1
LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
P25Y
CY2023Q2 elan Tax Incremental Financing Estimated Total Incentive To Be Funded
TaxIncrementalFinancingEstimatedTotalIncentiveToBeFunded
64000000 usd
CY2021Q4 elan Tax Incremental Financing Commitment Amount
TaxIncrementalFinancingCommitmentAmount
64000000 usd
CY2022Q4 elan Tax Incremental Financing Expect To Refund Within Next Three Months
TaxIncrementalFinancingExpectToRefundWithinNextThreeMonths
15000000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
492600000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
488400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
491800000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
488200000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492600000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
488400000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492700000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
492100000 shares
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3200000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001739104-23-000013-index-headers.html Edgar Link pending
0001739104-23-000013-index.html Edgar Link pending
0001739104-23-000013.txt Edgar Link pending
0001739104-23-000013-xbrl.zip Edgar Link pending
elan-20230630.htm Edgar Link pending
elan-20230630.xsd Edgar Link pending
elan-20230630_g1.jpg Edgar Link pending
ex311elanco-20230630xceoce.htm Edgar Link pending
ex312elanco-20230630xcfoce.htm Edgar Link pending
ex32elanco-20230630xsectio.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
elan-20230630_def.xml Edgar Link unprocessable
elan-20230630_lab.xml Edgar Link unprocessable
elan-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
elan-20230630_cal.xml Edgar Link unprocessable
elan-20230630_htm.xml Edgar Link completed